THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED and MYLAN SPECIALTY L.P. |
EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LIMITED, MANKIND PHARMA LTD., LIFESTAR PHARMA LLC, TEVA PHARMACEUTICALS, INC., TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD., INTAS PHARMACEUTICALS LTD., LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC., ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, CIPLA LIMITED and CIPLA USA, INC. |
1:2023cv00926 |
February 16, 2023 |
US District Court for the District of New Jersey |
Ann Marie Donio |
Karen M Williams |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on April 12, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 25 Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for Orbicular. (Attachments: #1 Text of Proposed Order)(CALMANN, ARNOLD) |
Filing 24 Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for the Eugia Defendants. (Attachments: #1 Text of Proposed Order)(CALMANN, ARNOLD) |
Filing 23 Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Stipulation and Proposed Order for Waiver of Service of the Complaint and an Extended Answer Deadline for the Cipla Defendants. (Attachments: #1 Text of Proposed Order)(CALMANN, ARNOLD) |
Set/Reset Deadlines as to #22 MOTION for Leave to Appear Pro Hac Vice . Motion set for 5/1/2023 before Magistrate Judge Ann Marie Donio. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (dmr) |
Filing 22 MOTION for Leave to Appear Pro Hac Vice by TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. (Attachments: #1 Certification of Elaine Herrmann Blais, #2 Certification of Eric. T. Romeo, #3 Certification of Kristin M. Beale, #4 Certification of Liza M. Walsh, #5 Statement in Lieu of Brief, #6 Text of Proposed Order)(WALSH, LIZA) |
Filing 21 STIPULATION AND ORDER Regarding Dismissing Without Prejudice Defendant Lupin Ltd. Amending Caption to Reflect the Same and Personal Jurisdiction, Venue, and Discovery. Signed by Judge Karen M. Williams on 3/24/2023. (dmr) |
Filing 20 Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: #1 Text of Proposed Order)(CALMANN, ARNOLD) |
Filing 19 NOTICE of Appearance by JAMES S. RICHTER on behalf of LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC. (RICHTER, JAMES) |
Filing 18 STIPULATION AND ORDER Regarding Dismissing Without Prejudice Defendants Accord Healthcare, Ltd. and Intas Pharmaceuticals. Ltd. Amending Caption to Reflect the Same and Personal Jurisdiction Venue, and Discovery. Signed by Judge Karen M. Williams on 3/17/2023. (dmr) |
Filing 17 NOTICE of Appearance by JESSICA K. FORMICHELLA on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (FORMICHELLA, JESSICA) |
Filing 16 NOTICE of Appearance by CHRISTINE INTROMASSO GANNON on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (GANNON, CHRISTINE) |
Filing 15 NOTICE of Appearance by LIZA M. WALSH on behalf of TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC. (WALSH, LIZA) |
Filing 14 LETTER ORDER granting Plaintiff's request to adjourn the April 11, 2023 Initial Conference. Signed by Magistrate Judge Ann Marie Donio on 3/16/2023. (dmr) |
Filing 13 Letter from Arnold B. Calmann, Esq. to the Honorable Ann Marie Donio, U.S.M.J. Requesting Adjournment of Rule 16 Conference and Related Deadlines re #11 Order Initial Scheduling Conference (Camden). (CALMANN, ARNOLD) |
Filing 12 Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. Enclosing Proposed Stipulation and Order. (Attachments: #1 Text of Proposed Order)(CALMANN, ARNOLD) |
Filing 11 Order Initial Conference set for 4/11/2023 at 10:30 AM in Camden - Courtroom 3B before Magistrate Judge Ann Marie Donio. Signed by Magistrate Judge Ann Marie Donio on 3/13/2023. (dmr) |
Filing 10 Corporate Disclosure Statement by MANKIND PHARMA LTD. identifying Mankind Pharma Ltd. as Corporate Parent.. (SHELHOFF, DMITRY) |
Filing 9 Mankind Pharma Ltd and Lifestar Pharma LLC's ANSWER to Complaint of Theravance Biopharma et al. by MANKIND PHARMA LTD..(SHELHOFF, DMITRY) |
Filing 8 NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of LIFESTAR PHARMA LLC (SHELHOFF, DMITRY) |
Filing 7 NOTICE of Appearance by DMITRY V. SHELHOFF on behalf of MANKIND PHARMA LTD. (SHELHOFF, DMITRY) |
Filing 6 NOTICE of Appearance by KATHERINE ANN ESCANLAR on behalf of MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. (ESCANLAR, KATHERINE) |
Filing 5 AO120 Patent/Trademark Form filed. (ssp, ) |
Filing 4 SUMMONS ISSUED as to ACCORD HEALTHCARE, INC., ACCORD HEALTHCARE, LTD., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., CIPLA LIMITED, CIPLA USA, INC., EUGIA PHARMA SPECIALTIES LTD., EUGIA US LLC, INTAS PHARMACEUTICALS LTD., LIFESTAR PHARMA LLC, LUPIN INC., LUPIN LTD., LUPIN PHARMACEUTICALS, INC., MANKIND PHARMA LTD., ORBICULAR PHARMACEUTICAL TECHNOLOGIES PRIVATE LIMITED, TEVA PHARMACEUTICAL INDUSTRIES LTD., TEVA PHARMACEUTICALS USA, INC., TEVA PHARMACEUTICALS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (ssp, ) |
Notice of Judicial Preferences. #Click here for the Judge's Individual Procedure Requirements. (ssp, ) |
Magistrate Judge Ann Marie Donio added. (dmw) |
Filing 3 Corporate Disclosure Statement by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P. identifying Viatris Inc. as Corporate Parent.. (CALMANN, ARNOLD) |
Filing 2 Corporate Disclosure Statement by THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC. identifying Theravance Biopharma, Inc. as Corporate Parent.. (CALMANN, ARNOLD) |
Filing 1 COMPLAINT against All Defendants ( Filing and Admin fee $ 402 receipt number ANJDC-14046614), filed by THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA IRELAND LIMITED, MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P.. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet)(CALMANN, ARNOLD) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.